🧬Immunotherapy / Immuno-Oncology
Market Cap$95.3B
1D-1.13%
Companies456
Public Cos53
SECTOR MARKET CAP
$95.3B+1135.7%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Germany | $22.4B | BNTX |
| 2 |  | China | $13.6B | 9926.HK |
| 3 |  | United States | $8.7B | IBRX |
| 4 |  | Japan | $6.9B | 4528.T |
| 5 |  | United States | $6.7B | ACLX |
| 6 |  | Denmark | $6.4B | ALK-B.CO |
| 7 |  | United States | $5.5B | CGON |
| 8 |  | United States | $1.5B | IOVA |
| 9 |  | United Kingdom | $1.5B | IMCR |
| 10 |  | United States | $1.5B | VIR |
| 11 |  | Germany | $1.3B | IMTX |
| 12 |  | United States | $1.2B | ZBIO |
| 13 |  | United States | $1.2B | BCAX |
| 14 |  | Switzerland | $1.2B | MLTX |
| 15 |  | United States | $1.2B | PGEN |
| 16 |  | France | $1.1B | DBVT |
| 17 |  | United States | $855.3M | JANX |
| 18 |  | United States | $854.6M | SLS |
| 19 |  | United States | $577.4M | XLO |
| 20 |  | United States | $576.4M | REPL |